FDA Approves Pluvicto Plus Hormone Therapy for Certain Patients With Metastatic Prostate Cancer

Regulatory Approvals — FDA Approves Pluvicto Plus Hormone Therapy for Certain Patients With Metastatic Prostate Cancer  Cure Today

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. July 31, 2026.

By